Vagus Nerve Stimulation for Fibromyalgia

(R61VNS Trial)

LC
Overseen ByLucy Chen, M.D.
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Massachusetts General Hospital
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether stimulating the vagus nerve through the skin can relieve pain and other symptoms in people with fibromyalgia. Fibromyalgia is a chronic condition causing widespread pain and fatigue, and scientists are still investigating its causes. Participants will receive either the actual nerve stimulation treatment, known as Transcutaneous Vagus Nerve Stimulation (tVNS), or a sham version to compare effects. Ideal candidates for this trial have been diagnosed with fibromyalgia for at least three months and regularly experience significant pain. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could lead to new treatment options for fibromyalgia.

What prior data suggests that transcutaneous vagus nerve stimulation (tVNS) is safe for fibromyalgia patients?

Research has shown that using a device on the skin to stimulate the vagus nerve, known as transcutaneous vagus nerve stimulation (tVNS), is generally safe for people with fibromyalgia. Studies have found that tVNS, a noninvasive treatment, can help reduce pain in those with fibromyalgia. These studies reported no serious side effects. Some minor side effects, such as difficulty swallowing or temporary changes in voice, were noted but did not last long. Overall, tVNS appears to be a promising and safe option for managing pain in fibromyalgia.12345

Why are researchers excited about this trial?

Unlike the standard treatments for fibromyalgia, which typically involve medications like antidepressants, anticonvulsants, and pain relievers, Transcutaneous Vagus Nerve Stimulation (tVNS) offers a non-drug approach. Researchers are excited about tVNS because it uses electrical impulses to stimulate the vagus nerve through the skin, potentially reducing pain and improving mood without the side effects associated with medication. This technique targets the nervous system directly, which may provide relief more efficiently and with fewer side effects than conventional drug therapies. Additionally, its non-invasive nature means it could be a more accessible and safer option for patients.

What evidence suggests that transcutaneous vagus nerve stimulation might be an effective treatment for fibromyalgia?

Research has shown that transcutaneous vagus nerve stimulation (tVNS), a treatment participants in this trial may receive, might help people with fibromyalgia by reducing pain and improving quality of life. Studies have found that tVNS can significantly decrease pain levels in patients and enhance overall well-being and muscle strength. This treatment likely works by calming the nervous system and reducing inflammation, both of which are issues in fibromyalgia. Overall, tVNS appears to be a promising, safe, and effective way to manage fibromyalgia symptoms.678910

Who Is on the Research Team?

LC

Lucy Chen, M.D.

Principal Investigator

Massachusetts General Hospital

Are You a Good Fit for This Trial?

This trial is for adults diagnosed with fibromyalgia who are seeking new ways to manage their pain and symptoms. Specific inclusion or exclusion criteria were not listed, but generally participants should be able to use a non-invasive device and follow study instructions.

Inclusion Criteria

My pain level is 4 or higher on a scale from 0 to 10.
I am between 18 and 80 years old.
I have been diagnosed with fibromyalgia for at least three months.

Exclusion Criteria

Subject has major psychiatric disorder requiring hospitalization in the last 3 months
Subject is pregnant
I have an irregular heartbeat or a pacemaker/AICD device.
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either active tVNS treatment or a sham treatment for 6 weeks, with sessions twice a day for 30 minutes each

6 weeks
Regular sessions twice daily

Follow-up

Participants complete a follow-up phone call to assess pain levels and any side effects

2 weeks
1 follow-up phone call

What Are the Treatments Tested in This Trial?

Interventions

  • Transcutaneous Vagus Nerve Stimulation (tVNS)

Trial Overview

The study tests whether using a device called VagaCalm, which stimulates the vagus nerve through the skin (transcutaneous vagus nerve stimulation), can help reduce pain and other symptoms in people with fibromyalgia.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Transcutaneous Vagus Nerve Stimulation (tVNS)Experimental Treatment1 Intervention
Group II: Sham Control GroupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Massachusetts General Hospital

Lead Sponsor

Trials
3,066
Recruited
13,430,000+

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Collaborator

Trials
508
Recruited
1,090,000+

Citations

Vagus Nerve Stimulation(VNS) As Treatment For ...

The investigators propose to examine the hypothesis that vagus nerve stimulation could improve pain and related comorbid symptoms for FM patients.

Vagus Nerve Stimulation(VNS) As Treatment For ...

The investigators propose to examine the hypothesis that vagus nerve stimulation could improve pain and related comorbid symptoms for FM ...

Transcutaneous Auricular Vagal Nerve Stimulation Against ...

Fatigue and quality of life improved in all groups, but no differences were observed between them. taVNS appears safe and well accepted, but did not reduce ...

Vagus Nerve Stimulation: A New Hope for Fibromyalgia ...

Both studies reported promising outcomes, with a significant reduction in pain intensity and an overall improvement in the patients' quality of life.

Effects of transcutaneous vagus nerve stimulation on chronic ...

All six trials found that TVNs were beneficial in lowering pain intensity, boosting quality of life, back muscular endurance, and functional ...

Vagus Nerve Stimulation(VNS) As Treatment For ...

The primary outcome measure will be pain intensity. The secondary outcome measures will be fatigue, sleep, and other health-related quality of life measure. a ...

Vagus Nerve Stimulation in Fibromyalgia - ClinicalTrials.Veeva

Vagus nerve stimulation is thought to reduce sympathetic nerve outflow and so can improve sympathetic hyperactivity in fibromyalgia patients.

The Effect of Vagus Nerve Stimulation on Pain Severity Scores ...

Across included studies, the pooled effect size demonstrated a significant mean improvement in pain severity from pre-treatment to post-treatment of 2.32 points ...

Vagus Nerve Stimulation in Fibromyalgia

Vagus nerve stimulation is thought to reduce sympathetic nerve outflow and so can improve sympathetic hyperactivity in fibromyalgia patients.

Safety and Efficacy of Vagus Nerve Stimulation in Fibromyalgia

Preliminary outcome measures suggested that VNS may be a useful adjunct treatment for FM patients resistant to conventional therapeutic management, but further ...